As Itgav has been shown to partner with ITGB3 to form a heterodimeric integrin receptor in a variety of cells (Savill et al., 1990), including a number of cancers (Eliceiri and Cheresh, 2001), we investigated the expression of ITGB3 in the stem cell sub-populations. Here, ITGAV is linked to cancer.